Article
Complex rearrangements fuel ER+ and HER2+ breast tumours
8 Jan 2025
Abstract excerpt
Breast cancer is a highly heterogeneous disease whose prognosis and treatment as defined by the expression of three receptors—oestrogen receptor (ER), progesterone receptor and human epidermal growth factor receptor 2 (HER2; encoded by ERBB2)—is insufficient to capture the full spectrum of clinical outcomes and therapeutic vulnerabilities. Previously, we demonstrated that transcriptional and genomic profiles...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
